KCM
SAGE

Kingdon Capital Management’s Sage Therapeutics SAGE Stock Holding History

Kingdon Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-146,179
Closed -$14M – 77
2018
Q4 		$14M Buy
+146,179
New +$16.7M 2.44% 18
2018
Q2 		– Sell
-35,518
Closed -$5.72M – 142
2018
Q1 		$5.72M Sell
35,518
-94,998
-73% -$16.1M 0.49% 68
2017
Q4 		$21.5M Buy
+130,516
New +$12.7M 1.9% 21
2017
Q1 		– Sell
-274,339
Closed -$14M – 145
2016
Q4 		$14M Sell
274,339
-232,651
-46% -$11M 0.97% 50
2016
Q3 		$23.3M Buy
506,990
+316,890
+167% +$12.9M 1.53% 22
2016
Q2 		$5.73M Buy
+190,100
New +$6.34M 0.46% 74

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return